Latest / Bloomberg Intelligence / Musk Turns to Tesla and SpaceX to Fuel AI Ambitions

Transcript

Musk Turns to Tesla and SpaceX to Fuel AI Ambitions · Bloomberg Intelligence

0:02
Speaker 1: Bloomberg Audio Studios, podcasts, radio news. You're listening to the
0:10
Speaker 1: Bloomberg Intelligence Podcast. Catch us live weekdays at ten am
0:14
Speaker 1: Eastern on Applecarclay, and Android Auto with the Bloomberg Business App.
0:18
Speaker 1: Listen on demand wherever you get your podcasts, or watch
0:21
Speaker 1: us live on YouTube.
0:23
Speaker 2: Tesla shares they are higher this morning. They're up about
0:26
Speaker 2: three tens of percent, but there were some news. Elon
0:28
Speaker 2: Musk said the company plans to pull Tesla's shareholders on
0:32
Speaker 2: whether to invest in his other company, that's x Ai.
0:36
Speaker 2: So here to break it all down for us is
0:37
Speaker 2: Craig Trudeli's Bloomberg Global Auto editor.
0:41
Speaker 3: Craig I have to.
0:42
Speaker 2: Ask you, you know, this is something that came out. I mean,
0:44
Speaker 2: what kind of message is this sending.
0:48
Speaker 3: It's sending that, you know, Elon's Elon's business empire is
0:53
Speaker 3: becoming all the more intertwined. So this has been, you know,
0:56
Speaker 3: sort of a case on and off for years. We
1:00
Speaker 3: can think back to say, you know, the Tesla Solar
1:03
Speaker 3: City acquisition, you know, and that's going back quite a
1:08
Speaker 3: way is but uh, you know, in this case it
1:10
Speaker 3: would be Tesla, you know, his most valuable company in
1:15
Speaker 3: investing in in sort of his up and comer and
1:18
Speaker 3: one where he's you know, spent an awful lot of
1:20
Speaker 3: time and energy focused on. Lately, as Tesla's electric vehicle
1:25
Speaker 3: sales have been slowing, he's been really sort of dead
1:28
Speaker 3: set on taking on open Open AI and and sort
1:32
Speaker 3: of standing up a competitor to chat GPT and as
1:36
Speaker 3: with all the companies in the space, spending an awful
1:39
Speaker 3: lot of money to to try and compete in that realm.
1:43
Speaker 4: So where do we stand here in terms of kind
1:47
Speaker 4: of how investors are viewing their investment in Tesla. Are
1:50
Speaker 4: they invested in a auto company or are they invested
1:53
Speaker 4: in an AI company? Or they invested just an Elon Inc?
1:57
Speaker 4: How did they think about it these days?
1:59
Speaker 3: Yeah? I mean, I think Musk has has been trying
2:02
Speaker 3: for for several years now to to sell uh and
2:05
Speaker 3: and position Tesla as much more than just a car company, right,
2:08
Speaker 3: and uh, you know it's it's definitely in in the
2:12
Speaker 3: energy space and and uh you know has a battery
2:16
Speaker 3: business to to show for that, and in in AI.
2:19
Speaker 3: You know, he's he's talked a big game about uh,
2:22
Speaker 3: you know, developing self driving technology. He's not he's not
2:26
Speaker 3: gotten there yet. Uh as as we've seen with the company,
2:30
Speaker 3: you know, starting to offer rides in in Tesla's around Austin, Texas. Uh,
2:35
Speaker 3: they still have uh you know, Tesla employees in the
2:38
Speaker 3: front passenger seat to sort of take over in events
2:41
Speaker 3: where you know, the cars have not been able to
2:43
Speaker 3: handle uh, you know, navigating the streets on their own.
2:47
Speaker 3: And and yet with with uh SpaceX, I think interest interestingly,
2:51
Speaker 3: you know, for them to have just pumped two billion
2:54
Speaker 3: into h x AI, I think there's a little bit
2:57
Speaker 3: of fomo on the part of of some the Tesla
3:00
Speaker 3: shareholder base where they've seen you know, XAI go from
3:05
Speaker 3: you know, not all that valuable a startup to suddenly,
3:08
Speaker 3: you know, an extremely valuable startup and they feel like
3:12
Speaker 3: they've missed out on some of this appreciation and one
3:15
Speaker 3: in on that.
3:16
Speaker 2: So with all that said, Craig, I mean, does must
3:18
Speaker 2: support a merger between x AI and Tesla or maybe
3:22
Speaker 2: x a hind SpaceX you mentioned space X two.
3:26
Speaker 3: He says he does not. And and I think there's
3:28
Speaker 3: been talk about this for years, right that, you know,
3:30
Speaker 3: and on and off again there's been you know, questions
3:33
Speaker 3: as to whether or not Musk is you know, sort
3:35
Speaker 3: of stretched too thin and doing too much. Would it
3:38
Speaker 3: make more sense to turn his companies into into one
3:42
Speaker 3: and and sort of you know, sort of the think
3:46
Speaker 3: about it as sort of the general Electric of the
3:49
Speaker 3: New age, right, which is kind of fascinating because of
3:52
Speaker 3: course that didn't work out too well for ge. And
3:56
Speaker 3: and yet you know, even some of Musk's own out
4:00
Speaker 3: have sort of alluded to, you know, it's viewing him
4:05
Speaker 3: and his empire as as sort of you know, modern
4:07
Speaker 3: day general Electric. So he he did take pains to
4:12
Speaker 3: say on an x that he does not support a
4:15
Speaker 3: full blown merger of Tesla and x Ai, but he
4:19
Speaker 3: has you know, signals on there multiple times now that
4:22
Speaker 3: he would be in favor of of Tesla putting money
4:25
Speaker 3: in and you know that's that's, of course, you know,
4:29
Speaker 3: a proposition that could be helpful if Xai continues to
4:34
Speaker 3: grow its valuation. We should note, however, that our colleagues
4:38
Speaker 3: have reported just in the last month or so that
4:40
Speaker 3: x Ai has been burning through about a billion dollars
4:43
Speaker 3: a month. So this is a company that is really
4:47
Speaker 3: sort of cash hungry and needy as it's trying to
4:50
Speaker 3: stand up a business. You know, with all of this capability.
4:54
Speaker 4: Yeah, and Craig, it's been I don't know a month
4:56
Speaker 4: or two since Elon Musk left the US government, doje
5:00
Speaker 4: is there any evidence that he is meaningfully engaging with Tesla?
5:05
Speaker 3: You know, I think he's messaging more about, you know,
5:09
Speaker 3: sort of what Tesla's up to than he was while
5:12
Speaker 3: he was in Washington. He did also post just within
5:16
Speaker 3: the last day that you know, he was in Tesla's
5:19
Speaker 3: design studio and sort of hyped up how excited he
5:23
Speaker 3: was about what he saw. But you know, the company
5:27
Speaker 3: is is, you know, sort of in this really sort
5:30
Speaker 3: of challenging state from a sales perspective, and you've you've
5:34
Speaker 3: sort of gotten indications that, well, maybe he doesn't necessarily
5:37
Speaker 3: fully have his his finger on the pulse in the
5:40
Speaker 3: sense that he told us just within the last few
5:43
Speaker 3: months that sales have turned around. You know, a couple
5:46
Speaker 3: of months later, the company reports that its vehicle deliveries
5:49
Speaker 3: had fallen thirteen percent in the second quarter. So either
5:53
Speaker 3: he was you know, not necessarily up to speed on
5:56
Speaker 3: the state of sales, or perhaps he was optimist more
5:59
Speaker 3: optimal stick that they were able to is going to
6:02
Speaker 3: be able to turn things around. Then they ultimately were
6:04
Speaker 3: able to last quarter.
6:05
Speaker 5: Okay, Greg, thanks so much for your reporting. Appreciate it.
6:07
Speaker 4: Kraig Trudeau is a Global autos editor for Bloomberg News.
6:11
Speaker 4: He's based in London, joining us via zoom.
6:13
Speaker 1: Here you're listening to the Bloomberg Intelligence podcast. Catch us
6:18
Speaker 1: live weekdays at ten am Eastern on Apple, Cocklay and
6:22
Speaker 1: Android Auto with the Bloomberg Business app. Listen on demand
6:25
Speaker 1: wherever you get your podcasts, or watch us live on YouTube.
6:29
Speaker 2: This is Bloomberg Intelligence. I'm Lisa Minteo alongside Paul Sweeney. Paul, So,
6:33
Speaker 2: summer barbecue. You think hot dogs, right, Robert? Okay, what's
6:36
Speaker 2: your favorite?
6:37
Speaker 5: What's you go to? Hot dog? Oscar myern the question,
6:40
Speaker 5: Oh yes, okay.
6:41
Speaker 2: See I'm a Brooklyn girl.
6:42
Speaker 5: I go Nathan's.
6:42
Speaker 2: But okay, that's title said. There are some big news
6:46
Speaker 2: when it comes to your barbecue. So a company may
6:48
Speaker 2: be splitting up sources in craft hends, could break itself up,
6:52
Speaker 2: spin off into this large part of the business, into
6:54
Speaker 2: this new entity.
6:56
Speaker 5: What is this all about?
6:57
Speaker 2: Let's bring it someone who knows about it. Jennifer bartash
7:00
Speaker 2: More Intelligence senior analysts Retail staples and package food Jennifer.
7:05
Speaker 2: I know it's sources are saying a lot of things.
7:07
Speaker 2: What's the latest that you're hearing about this breakup?
7:09
Speaker 6: Yeah, good morning. So this is an interesting breakup because
7:13
Speaker 6: it's ten years after they merge together, and it seems
7:16
Speaker 6: that the main portions of that initial merger are going
7:19
Speaker 6: there will go their separate ways. The way we look
7:22
Speaker 6: at it, it looks like there's a core group of
7:24
Speaker 6: what they consider their taste Elevation platform, which is what
7:27
Speaker 6: is in the seasonings Taste Elevation.
7:30
Speaker 4: Oh please, that's Gott mackenzie written all over. It has
7:34
Speaker 4: that spices and Condiments.
7:36
Speaker 6: That's Spices inc. Yeah, exactly, and then they have you know,
7:41
Speaker 6: that's kind of been their growth area for the last
7:43
Speaker 6: couple of years. So we think that that's really going
7:45
Speaker 6: to be what will be the residual part of Heinz.
7:48
Speaker 6: And then there is it's undetermined yet exactly what'll go
7:51
Speaker 6: into the rest of the business, but it'll be largely
7:54
Speaker 6: those grocery categories where they've invested a lot to try
7:57
Speaker 6: to revitalize brands and it just hasn't worked in terms
8:00
Speaker 6: of really rejuvenating sales.
8:03
Speaker 4: You know, when I think about brands in the shop,
8:05
Speaker 4: you know, going to the supermarket. Boy, those house brands
8:09
Speaker 4: private label. Talk to us about the growth of private
8:12
Speaker 4: label in general, Boy, and if you're a brand like
8:14
Speaker 4: an Oscar Meyer or something that you spent jillions of
8:16
Speaker 4: dollars over one hundred years, it seems to kind of
8:20
Speaker 4: go by the wayside almost.
8:22
Speaker 6: It's true. You've got a good point, Paul. Private label
8:24
Speaker 6: has been consistently growing and got a huge bump since
8:27
Speaker 6: the pandemic. And part of that is that they've the
8:31
Speaker 6: retailers have really invested in the quality and the the
8:35
Speaker 6: differentiation of those private label brands, so where consumers now
8:38
Speaker 6: really consider them not just a replacement for national brands,
8:41
Speaker 6: but in some instances just regular brands of their own right.
8:46
Speaker 6: And so you know, Craft Times actually had reduced some
8:48
Speaker 6: of its exposure to private label when they sold off
8:51
Speaker 6: the planter's business, when they sold off the cheese like
8:54
Speaker 6: the shredded cheese business with Craft, but the core grocery
8:58
Speaker 6: business they do still have a lot of exposure to
9:00
Speaker 6: private label.
9:00
Speaker 2: So is this a lot of competition from let's say,
9:03
Speaker 2: startup food companies appealing to younger consumers? I mean, what
9:06
Speaker 2: kind of sparked this.
9:08
Speaker 6: Well, there's really been a shift in the way consumers
9:11
Speaker 6: are looking at brands. Unless you own a long legacy
9:16
Speaker 6: brand that you can reinvent and really you know, drive
9:19
Speaker 6: interest from younger generations, it's really hard to keep that going.
9:24
Speaker 6: And so what we've seen is that they've done a
9:27
Speaker 6: good job with revitalizing things like Philly Cream cheese. But
9:31
Speaker 6: despite a lot of investment, brands like Caprice, son Oscar Meyer, Maxwellhouse,
9:37
Speaker 6: you know, these brands just aren't resonating with younger consumers,
9:40
Speaker 6: and that means that the growth prospects for those brands
9:43
Speaker 6: are a lot lower, and that makes it hard to
9:46
Speaker 6: really build yourself as a growth type oriented company.
9:50
Speaker 4: So I know, as I think back to my M
9:51
Speaker 4: and A Memory Banks ten years ago, Crafton Hines Berkshire
9:55
Speaker 4: Hathaway had a big hand in putting these two companies together,
9:58
Speaker 4: and look now they're still the largest shareholder with just
10:01
Speaker 4: under twenty eight percent of the stock. I assume Berkshire
10:04
Speaker 4: Hathaway Warren Buffet has kind of signed off on this
10:07
Speaker 4: deal or is open to it.
10:08
Speaker 6: At least I would assume that they're open to it,
10:11
Speaker 6: you know, I mean over time, you know, Berkshire Hathway
10:13
Speaker 6: has actually done quite well out of this deal, even
10:16
Speaker 6: though Kraft, heindes as an overall entity, is probably disappointed
10:21
Speaker 6: in the overall analysis. But you know, the merger was
10:25
Speaker 6: in twenty fifteen. It's been ten ten years. The value
10:29
Speaker 6: of the deal at the time in twenty fifteen was
10:31
Speaker 6: forty five billion dollars. Today's market cap it's thirty two
10:34
Speaker 6: billion dollars, so it you know, and yes they've sold
10:37
Speaker 6: off a couple of brands, but it just hasn't materialized
10:40
Speaker 6: to be the type of growth that I think Berkshire
10:42
Speaker 6: Hathway and initially envisioned it would happen.
10:44
Speaker 2: Tenfer can you dig more into some of the advantages
10:47
Speaker 2: but also the risks associated with breaking up the company.
10:51
Speaker 6: Some you know, obviously some of the advantages. And this
10:55
Speaker 6: seems very similar to what Kellogg did when they spun
10:57
Speaker 6: Kelenova and W. K. Kellogg out into two separate companies.
11:01
Speaker 6: They separated the growth prospects and then those from the
11:05
Speaker 6: slow growth areas. That's very similar to what Kraft Time
11:09
Speaker 6: seems Craft Time seems to be doing. Obviously, if you
11:14
Speaker 6: can focus on growth areas, that gives you undivided attention
11:18
Speaker 6: to really expand and grow. That would be an advantage,
11:21
Speaker 6: I think one of the disadvantages, And this is something
11:24
Speaker 6: that's kind of a broader question to consider, is you know,
11:27
Speaker 6: whether there's a cycle that's starting because we've seen companies
11:31
Speaker 6: like Kelenova split, we see Unilevers spinning off their ice
11:34
Speaker 6: cream business, and those new entities are now being bought
11:39
Speaker 6: up by others. So you've got Mars acquiring Kelenova, you
11:42
Speaker 6: have Ferrero acquiring W. K. Kellogg. But those in order
11:48
Speaker 6: to get regulatory approval, you have to have categories that
11:51
Speaker 6: aren't overlapping. And so you're you're you're seeing a new
11:55
Speaker 6: birth of new kind of conglomerates, of dissimilar portfolios. And
11:59
Speaker 6: so it makes me wonder if we're setting up another
12:01
Speaker 6: cycle where in another five years, ten years, we're going
12:05
Speaker 6: to see these companies that have been buying up the
12:07
Speaker 6: underperforming brands going through a similar type of activity.
12:11
Speaker 5: What's driving all this?
12:12
Speaker 4: It doesn't it feel like this MNA activity, whether you're
12:15
Speaker 4: buying or divesting, is out of a position of strength.
12:18
Speaker 4: It always feels like I don't know, I'm just I'm
12:21
Speaker 4: doing it because anami growth. Then I got to do something.
12:24
Speaker 4: I got pressure from shareholders to do something. So I'm
12:26
Speaker 4: either buying or selling because your business doesn't have a
12:30
Speaker 4: lot of growth.
12:31
Speaker 6: No, it's true, Paul, and I think one of the
12:34
Speaker 6: crises that we've sort of seen in packaged food at
12:36
Speaker 6: least is the North American companies is a lack of real,
12:39
Speaker 6: true innovation. So what's happened is a lot of companies
12:44
Speaker 6: have fallen into his pattern of innovation being a new
12:46
Speaker 6: flavor or a new extension, a new size of the product,
12:51
Speaker 6: and that's not really what gets consumers excited. You need
12:54
Speaker 6: to bring new and different products to market, and that's
12:57
Speaker 6: an expensive endeavor and companies have sort of shied away
13:01
Speaker 6: from that. And although they're trying to reinvigorate that innovation pipeline,
13:05
Speaker 6: we just haven't seen a lot of home runs coming
13:08
Speaker 6: out since the pandemic. And so, you know, I think
13:11
Speaker 6: when you've got that backdrop, you have to evaluate for
13:13
Speaker 6: your portfolio and say, how do we focus on the
13:15
Speaker 6: strengths that we have and can someone else do better
13:19
Speaker 6: with the categories where we're not doing as well?
13:22
Speaker 5: All right, Jen, thanks so much for joining us.
13:24
Speaker 4: Jim Bartasha is seening your retail Anams Bloomborg Intelligence, or
13:26
Speaker 4: at least the key question.
13:27
Speaker 5: You know Nathan's hothawks. Are you ketchup or mustard?
13:31
Speaker 2: Oh, mustard with salacrad and red onions.
13:33
Speaker 5: Okay, solid solid.
13:35
Speaker 4: I'm a mustard person too, But if somebody put a
13:38
Speaker 4: hot dog with ketchup in front of me, I would
13:39
Speaker 4: not eat it.
13:40
Speaker 5: Well, here's the thing.
13:41
Speaker 2: I just came back from Chicago and they said, if
13:43
Speaker 2: you put ketchup on your hot dog, no, that's a
13:46
Speaker 2: big no.
13:46
Speaker 6: No.
13:47
Speaker 5: They do not do that in Chicago. Okay, good, good
13:49
Speaker 5: to know, Good to know you. Yeah, you know.
13:52
Speaker 4: I'm definitely a mustard person. But again, you throw a
13:54
Speaker 4: hot dog in front of me with ketchup.
13:56
Speaker 5: Off, probably eat it as well.
14:00
Speaker 1: Listening to the Bloomberg Intelligence podcast catch us live weekdays
14:04
Speaker 1: at ten am Eastern on Applecarclay, and Android Auto with
14:07
Speaker 1: the Bloomberg Business app. Listen on demand wherever you get
14:10
Speaker 1: your podcasts, or watch us live on YouTube.
14:13
Speaker 2: Welcome back to the Bloomberg Intelligence. I'm Lisa Matteo alongside
14:16
Speaker 2: Paul Sweeney, Weight.
14:17
Speaker 5: Loss, drugs, right, all the rage. I always want to
14:20
Speaker 5: know what.
14:20
Speaker 2: Is the latest with it? So here with that and
14:23
Speaker 2: much more is Sam Fazelli, Bloomberg Intelligence, Director of Research
14:26
Speaker 2: for Global Industries and Senior Pharmaceuticals. Sam, thank you for
14:30
Speaker 2: joining us this morning. Just want to ask what is
14:32
Speaker 2: the latest because we hear so much about weight loss
14:34
Speaker 2: drugs and different companies. What's the latest you can here
14:37
Speaker 2: you've been hearing so far?
14:39
Speaker 1: Yeah, hi, Lisa.
14:40
Speaker 7: So in terms of what's happening in the market, we're
14:43
Speaker 7: still waiting to see whether the prescription counts for Novo
14:48
Speaker 7: Nordisks US WeGo V numbers are up or not. They've
14:53
Speaker 7: been flat for pretty much most of this year in
14:55
Speaker 7: terms of the number of scripts that doctors are writing
14:59
Speaker 7: for their we go V. And the opposite is the
15:02
Speaker 7: case for is Lily zeppound continues to keep going up
15:06
Speaker 7: and it's a it's a pretty interesting battle which seems
15:11
Speaker 7: to be currently being won by Lily, and time will tell.
15:14
Speaker 7: What is interesting is that my colleague A. Girzbacker just
15:18
Speaker 7: finished a deep patent analysis for so Astria exactly Paul
15:24
Speaker 7: for we go V, and I mean the dates in
15:29
Speaker 7: terms of pattern experience. Of course, they're important because that's
15:31
Speaker 7: when generics can come in and compete with you. Here
15:34
Speaker 7: we go from possibly she says twenty thirty one, twenty
15:37
Speaker 7: thirty two in the US at least to twenty forty.
15:41
Speaker 7: I mean, look, that's an amazing outcome, and she puts
15:44
Speaker 7: a decent probability on it in terms of the ways
15:46
Speaker 7: that they could protect it. So that could mean a
15:49
Speaker 7: lot for a product that could be sending five or
15:51
Speaker 7: ten billion dollars a year.
15:52
Speaker 5: Right, all right, we got to go to the elephant
15:54
Speaker 5: in the room here.
15:55
Speaker 4: I mean, Jesus for our listeners on radio, Sam is
15:58
Speaker 4: in some kind of contraption like he I'm guessing he
16:02
Speaker 4: fell off a barstool and hurt his armor's shoulder.
16:04
Speaker 5: Here, what happens, Sammy.
16:06
Speaker 7: It's that cheap drink you guys selling the US. You know,
16:09
Speaker 7: it just doesn't work for me. What I need is
16:10
Speaker 7: are is classified growth, red wines and white wires, right.
16:14
Speaker 5: Pole, So what I mean, I'm assuming there's something going
16:17
Speaker 5: on there.
16:17
Speaker 7: So all right, so rotate tickoff surgery. It's a ard.
16:22
Speaker 5: He's not an athlete.
16:23
Speaker 4: Bottle He stopping a bottle of bordeaux, threw out his
16:26
Speaker 4: shoulder opening a bottle bordeaux. So talk to us about
16:31
Speaker 4: what's what's the latest on the cancer field?
16:33
Speaker 5: Sam I know you got a lot of conferences in
16:35
Speaker 5: here on top of the latest research.
16:38
Speaker 4: What should we as consumers and maybe even investors in
16:41
Speaker 4: healthcare stocks and biotext what should we be thinking about
16:44
Speaker 4: as the next frontier on the cancer front.
16:47
Speaker 7: Yeah, I mean, we have a bunch of conference's coming
16:51
Speaker 7: up very soon, so the Myloma Conference in International Maloma
16:55
Speaker 7: Society in September, the World Lung Cancer Congress, then there's
17:00
Speaker 7: the big European Society for Medical Oncology conference in October.
17:05
Speaker 7: During these we're going to hear about whether there's going
17:08
Speaker 7: to be big step changes again in the treatment of
17:12
Speaker 7: some diseases, particularly lung cancer. So we got some therapeutics
17:17
Speaker 7: with possibly some data coming up, maybe a door world
17:21
Speaker 7: lung cancer. We'll see the aura Desmo. And we've just
17:24
Speaker 7: done a survey of US physicians which came back with
17:28
Speaker 7: very interesting comments, which are going to write about tomorrow
17:30
Speaker 7: about some other trials that are ongoing. So we'll say
17:33
Speaker 7: I can't front run that the data will be published
17:36
Speaker 7: tomorrow on the terminal. But there's stuff still happening in
17:39
Speaker 7: cancer where we're seeing potential for paradigm shift, and that's
17:42
Speaker 7: some of the things that we'll be referring to tomorrow.
17:44
Speaker 7: Of course, in the middle of all this, we have
17:46
Speaker 7: farmer companies continue looking for products to expand their pipelines
17:51
Speaker 7: through M and A.
17:52
Speaker 2: Now, Sam, we've been talking a lot about tariffs lately.
17:56
Speaker 2: How is a biotech sector, even pharmaceuticals, if you can
17:58
Speaker 2: dig more into how they're being affected by tariffs.
18:03
Speaker 7: Yes, so that that's one area if you look at
18:05
Speaker 7: the performance of the farmer stocks relative to the rest
18:09
Speaker 7: of the market, I mean Max seven. I mean, I
18:12
Speaker 7: don't know where they're going, but Paul I'm sure knows
18:14
Speaker 7: more because of the background he has in analyzing tech.
18:18
Speaker 7: But they just keep going up. I mean, there's no
18:20
Speaker 7: there's no nowhere else for them to go if you
18:22
Speaker 7: put them aside. Okay, there s a B five hundred.
18:25
Speaker 7: Maybe hasn't been as magical as the when it includes
18:29
Speaker 7: the Max seven, but pharma has been a little even less,
18:33
Speaker 7: a bit more lackluster, partly because of this continuing conversation
18:38
Speaker 7: about tariffs. That two hundred percent is something that President
18:42
Speaker 7: Trump mentioned just very recently, although it's delayed till next year.
18:46
Speaker 7: You've got your most favored nation pricing that's coming up.
18:51
Speaker 7: You've got your possibility that the regulators are going to
18:55
Speaker 7: be We don't know where the regulators going in the minute,
18:58
Speaker 7: to be honest with you, positive, negative, favorable, not favorable
19:02
Speaker 7: for the evolution of regulatory framework in the US. So
19:05
Speaker 7: there's a lot of questions. And I know this is
19:08
Speaker 7: four's favorite word, uncertainty that still dogs at the pharma sector.
19:12
Speaker 5: Yep, that's certainly the case.
19:13
Speaker 4: So maybe you know, August one might be a date
19:15
Speaker 4: we get some more clarity there. Sam Fazelli, director of
19:17
Speaker 4: research for Global Industries and his senior pharmaceutical analysts for
19:20
Speaker 4: Bloomberg Intelligence. He's covalescing there in London and our London students,
19:25
Speaker 4: but he makes it into the studio folks, even with
19:27
Speaker 4: one arm in a sling. So we appreciate that playing
19:30
Speaker 4: herd out there for us.
19:31
Speaker 5: That's what happens when you get old, Lisa. You know,
19:33
Speaker 5: things happen. They just kind of go out and we
19:34
Speaker 5: can see you in a sleep.
19:36
Speaker 4: I hope, I hope, not exactly so, Sam Fazzelli. There so,
19:40
Speaker 4: and Emina, you mentioned M and A. I'm just so
19:43
Speaker 4: far in the first quarter. This is according to Sam's notes,
19:46
Speaker 4: so far in the first half thirty two billion of
19:50
Speaker 4: M and A in farmer thirteen deals.
19:53
Speaker 5: Last year it was.
19:55
Speaker 4: Sixteen billion for six sixteen deals, so dollar amounts certainly
20:00
Speaker 4: bigger this year.
20:01
Speaker 1: This is the Bloomberg Intelligence Podcast, available on Apple, Spotify,
20:06
Speaker 1: and anywhere else you get your podcasts. Listen live each weekday,
20:10
Speaker 1: ten am to noon Eastern on Bloomberg dot com, the
20:13
Speaker 1: iHeartRadio app, tune In, and the Bloomberg Business app. You
20:17
Speaker 1: can also watch us live every weekday on YouTube and
20:21
Speaker 1: always on the Bloomberg terminal